Risk factors for drug-induced gingival overgrowth

被引:184
|
作者
Seymour, RA [1 ]
Ellis, JS [1 ]
Thomason, JM [1 ]
机构
[1] Univ Newcastle Upon Tyne, Sch Dent, Dept Restorat Dent, Newcastle Upon Tyne NE2 4BW, Tyne & Wear, England
关键词
drug-induced gingival overgrowth; risk factors; phenytoin; cyclosporin; calculus channel blocker;
D O I
10.1034/j.1600-051x.2000.027004217.x
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Background/Aims: Drug-induced gingival overgrowth remains a significant problem for the periodontologist. Many patients medicated with the drugs implicated in this unwanted effect experience significant, recurrent gingival problems that, require repeated surgical excisions. In this review, we attempt to identify and quantify the Various "risk factors" associated with both the development and expression of the drug-induced gingival changes. Method: The risk factors appraised include age, sex, drug variables, concomitant medication, periodontal variables and genetic factors. Elucidation of such factors may help to identify "at risk patients" and then develop appropriate treatment strategies. Results: Of the factors identified, the only one that can be affected by the periodontologist is the patents' periodontal condition. However, drug variables and concomitant medication do impact upon the expression of gingival overgrowth. Conclusion: The identification of risk factors associated with both the prevalence and severity of drug-induced gingival overgrowth is important for all parties involved with this unwanted effect. Both periodontologist and patient have an important role to play in improving oral hygiene and gingival health. Likewise, there is always an opportunity to establish a close liaison between the patient's physician and the periodontologist to try and identify alternative drug regimens that can help reduce the impact of this unwanted effect.
引用
收藏
页码:217 / 223
页数:7
相关论文
共 50 条
  • [21] DRUG-INDUCED GINGIVAL OVERGROWTH: AN IN VITRO STUDY ON CYCLOSPORINE AND HUMAN GINGIVAL FIBROBLASTS
    Candotto, V
    Baj, A.
    Beltramini, G.
    Scarano, A.
    Palmieri, A.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2019, 33 (06): : 21 - 27
  • [22] The role of phosphatase and tensin homolog in drug-induced gingival overgrowth
    Cetinkaya, B. O.
    Pamuk, F.
    Keles, G. C.
    Ayas, B.
    Ozfidan, G. K.
    Kayisli, U.
    Arik, N.
    Horton, H.
    JOURNAL OF PERIODONTAL RESEARCH, 2014, 49 (03) : 307 - 313
  • [23] Mechanism of drug-induced gingival overgrowth revisited: a unifying hypothesis
    Brown, R. S.
    Arany, P. R.
    ORAL DISEASES, 2015, 21 (01) : E51 - E61
  • [24] Drug-induced gingival overgrowth: a study in the French Pharmacovigilance Database
    Bondon-Guitton, Emmanuelle
    Bagheri, Haleh
    Montastruc, Jean-Louis
    JOURNAL OF CLINICAL PERIODONTOLOGY, 2012, 39 (06) : 513 - 518
  • [25] Connective tissue growth factor in drug-induced gingival overgrowth
    Uzel, MI
    Kantarci, A
    Hong, HH
    Uygur, C
    Sheff, MC
    Firatli, E
    Trackman, PC
    JOURNAL OF PERIODONTOLOGY, 2001, 72 (07) : 921 - 931
  • [26] CHROMOSOMAL PROTEIN-PHOSPHORYLATION IN DRUG-INDUCED GINGIVAL OVERGROWTH
    PHIPPS, L
    BUCHANAN, JA
    JOURNAL OF DENTAL RESEARCH, 1990, 69 : 332 - 332
  • [27] Drug-induced gingival overgrowth impeding oral tracheal intubation
    Khodadad-Hossaini, A.
    Farrell, K.
    Gonzalez, R. M.
    ANAESTHESIA REPORTS, 2022, 10 (01)
  • [28] TGF β1 in drug-induced gingival overgrowth:: activation or synthesis?
    Morgan, CL
    Robertson, H
    Thomason, JM
    Kirby, JA
    Taylor, JJ
    JOURNAL OF DENTAL RESEARCH, 2000, 79 : 236 - 236
  • [29] Use of an argon laser to treat drug-induced gingival overgrowth
    Matson, JS
    Blankenau, R
    Keene, JJ
    JOURNAL OF THE AMERICAN DENTAL ASSOCIATION, 1998, 129 (01): : 78 - 83
  • [30] DISPOSITION OF NIFEDIPINE IN PLASMA AND GINGIVAL CREVICULAR FLUID IN RELATION TO DRUG-INDUCED GINGIVAL OVERGROWTH
    ELLIS, JS
    SEYMOUR, RA
    MONKMAN, S
    IDLE, JR
    JOURNAL OF PERIODONTAL RESEARCH, 1993, 28 (05) : 373 - 378